SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 455 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $64,000 | +30.6% | 690 | +9.5% | 0.01% | +33.3% |
| Q2 2021 | $49,000 | -15.5% | 630 | -19.2% | 0.01% | -33.3% |
| Q1 2021 | $58,000 | -32.6% | 780 | +54.2% | 0.01% | -35.7% |
| Q4 2020 | $86,000 | +21.1% | 506 | 0.0% | 0.01% | +16.7% |
| Q3 2020 | $71,000 | -37.2% | 506 | -28.3% | 0.01% | -42.9% |
| Q2 2020 | $113,000 | +63.8% | 706 | 0.0% | 0.02% | +40.0% |
| Q1 2020 | $69,000 | -23.3% | 706 | +0.9% | 0.02% | -6.2% |
| Q4 2019 | $90,000 | +500.0% | 700 | +250.0% | 0.02% | +433.3% |
| Q3 2019 | $15,000 | -50.0% | 200 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $30,000 | +25.0% | 200 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $24,000 | +9.1% | 200 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $22,000 | -72.8% | 200 | -60.0% | 0.01% | -72.7% |
| Q3 2018 | $81,000 | +22.7% | 500 | 0.0% | 0.02% | +15.8% |
| Q2 2018 | $66,000 | +266.7% | 500 | +66.7% | 0.02% | +111.1% |
| Q3 2016 | $18,000 | – | 300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
| Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
| Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
| Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
| Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
| STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
| Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
| CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
| RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
| Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |